eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008
February 11 2008 - 3:21PM
PR Newswire (US)
PHILADELPHIA, Feb. 11 /PRNewswire-FirstCall/ --
eResearchTechnology, Inc. (eRT), (NASDAQ:ERES), a leading provider
of centralized electrocardiographic (ECG) collection and
interpretation services including expert consultation and a
provider of eClinical technology and services (electronic data
capture and electronic patient reported outcomes solutions),
announced today that it will release its 2007 fourth quarter
results for the period ended December 31, 2007 on Tuesday, February
26, 2008 after the market closes. After the release, the Company
will host a conference call at 5:00 PM ET later that day. For the
conference call interested participants should dial 866-578-5771
when calling within the United States or 617-213-8055 when calling
internationally. Please use pass code 91743845. There will be a
playback available as well. To listen to the playback, please call
888-286-8010 when calling within the United States or 617-801-6888
when calling internationally. Please use pass code 46120621 for the
replay. This call is being webcast by Thomson Financial and can be
accessed at eRT's web site at http://www.ert.com/. The webcast may
also be accessed at Thomson's Institutional Investor website at
http://phx.corporate-ir.net/playerlink.zhtml?c=119164&s=wm&e=1764127
. The webcast can be accessed until February 26, 2009 on either
site. Based in Philadelphia, PA, eResearchTechnology, Inc.
(http://www.ert.com/) is a provider of technology and services to
the pharmaceutical, biotechnology and medical device industries on
a global basis. The company is a market leader in providing
centralized core-diagnostic electrocardiographic (ECG) technology
and services to evaluate cardiac safety in clinical development.
The company is also a leader in providing technology and services
to streamline the clinical trials process by enabling its customers
to automate the collection, analysis, and distribution of clinical
data in all phases of clinical development. Statements included in
this release may constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Such statements involve a number of risks and uncertainties such as
competitive factors, technological development, market demand, and
the company's ability to obtain new contracts and accurately
estimate net revenues due to variability in size, scope and
duration of projects, and internal issues in the sponsoring client.
As a result, actual results may differ materially from any
financial outlooks stated herein. Further information on potential
factors that could affect the company's financial results can be
found in the company's Reports on Form 10-K and 10-Q filed with the
Securities and Exchange Commission. Contact: Richard Baron Robert
East eResearchTechnology, Inc. Westwicke Partners, LLC 215-282-5566
410-321-9652 DATASOURCE: eResearchTechnology, Inc. CONTACT: Richard
Baron of eResearchTechnology, Inc., +1-215-282-5566, or Robert East
of Westwicke Partners, LLC, for eResearchTechnology, Inc.,
+1-410-321-9652 Web site: http://www.ert.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about East Resources Acquisition Company (NASDAQ): 0 recent articles
More Eresearch Technology Inc. (MM) News Articles